{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:17:25Z","timestamp":1781716645457,"version":"3.54.5"},"reference-count":143,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00210-024-03675-7","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T10:58:52Z","timestamp":1736852332000},"page":"6221-6238","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["MircoRNAs predict and modulate responses to chemotherapy in leukemic patients"],"prefix":"10.1007","volume":"398","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4824-3485","authenticated-orcid":false,"given":"Doha El-Sayed","family":"Ellakwa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Ahmed","family":"Abdelmalek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa M.","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takwa E.","family":"Ellakwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al-Hassan Soliman","family":"Wadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,14]]},"reference":[{"issue":"2","key":"3675_CR1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1620\/tjem.255.127","volume":"255","author":"S Afaghi","year":"2021","unstructured":"Afaghi S et al (2021) Prevalence and clinical outcomes of vitamin D deficiency in COVID-19 hospitalized patients: a retrospective single-center analysis. Tohoku J Exp Med 255(2):127\u2013134","journal-title":"Tohoku J Exp Med"},{"key":"3675_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1756-8722-6-21","volume":"6","author":"H Alachkar","year":"2013","unstructured":"Alachkar H, Santhanam R, Harb JG, Lucas DM, Oaks JJ, Hickey CJ et al (2013) Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemia. J Hematol Oncol 6:21. https:\/\/doi.org\/10.1186\/1756-8722-6-21","journal-title":"J Hematol Oncol"},{"issue":"3","key":"3675_CR3","doi-asserted-by":"crossref","first-page":"e23284","DOI":"10.1002\/jbt.23284","volume":"37","author":"HM Ali","year":"2023","unstructured":"Ali HM, Ellakwa DES, Elaraby NM, Zaher AM, Amr KS (2023) Study the association of microRNA polymorphisms (miR-146a, miR-4513) with the risk of coronary heart diseases in Egyptian population. J Biochem Mol Toxicol 37(3):e23284","journal-title":"J Biochem Mol Toxicol"},{"issue":"1","key":"3675_CR4","doi-asserted-by":"crossref","first-page":"9666","DOI":"10.1038\/s41598-019-46132-9","volume":"9","author":"R Alves","year":"2019","unstructured":"Alves R et al (2019) MicroRNA Signature Refine Response Prediction in CML. Sci Rep 9(1):9666","journal-title":"Sci Rep"},{"key":"3675_CR5","doi-asserted-by":"publisher","unstructured":"Alwaeely FA, Madlum KN, Alsaadi MA\u00a0(2021) Immunomodulatory effect of propolis on foxp3 gene expression in human peripheral blood mononuclear cells stimulated in vitro with pseudomonas aeruginosa Ag. Arch Razi Inst 76(4):887\u2013894. https:\/\/doi.org\/10.22092\/ari.2021.355389.1678","DOI":"10.22092\/ari.2021.355389.1678"},{"key":"3675_CR6","doi-asserted-by":"crossref","first-page":"106489","DOI":"10.1016\/j.leukres.2020.106489","volume":"100","author":"G Ambrosinom","year":"2021","unstructured":"Ambrosinom G, Ruberti S (2021) MicroRNAs as prognostic biomarkers in acute myeloid leukemia: a comprehensive review. Leuk Res 100:106489","journal-title":"Leuk Res"},{"issue":"2","key":"3675_CR7","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3390\/cancers11020236","volume":"11","author":"N Amodio","year":"2019","unstructured":"Amodio N et al (2019) Replacement of miR-155 elicits tumor suppressive activity and antagonizes bortezomib resistance in multiple myeloma. Cancers 11(2):236","journal-title":"Cancers"},{"issue":"November","key":"3675_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2020.581007","volume":"10","author":"T Annese","year":"2020","unstructured":"Annese T, Tamma R, De Giorgis M, Ribatti D (2020) microRNAs biogenesis, functions and role in tumor angiogenesis. Front Oncol 10(November):1\u201321. https:\/\/doi.org\/10.3389\/fonc.2020.581007","journal-title":"Front Oncol"},{"issue":"1","key":"3675_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cell.2018.03.006","volume":"173","author":"DP Bartel","year":"2018","unstructured":"Bartel DP (2018) Review metazoan microRNAs. Cell 173(1):20\u201351. https:\/\/doi.org\/10.1016\/j.cell.2018.03.006","journal-title":"Cell"},{"issue":"2","key":"3675_CR10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/ncrna9020027","volume":"9","author":"E Bayraktar","year":"2023","unstructured":"Bayraktar E, Bayraktar R, Oztatlici H, Lopez-Berestein G, Amero P, Rodriguez-Aguayo C (2023) Targeting miRNAs and other non-coding RNAs as a therapeutic approach: an update. Non-Coding RNA 9(2):27","journal-title":"Non-Coding RNA"},{"key":"3675_CR11","doi-asserted-by":"publisher","unstructured":"Bayraktar R, Van Roosbroeck K, Calin GA (2017) Cell-to-cell communication\u202f: microRNAs as hormones. 11:1673\u20131686https:\/\/doi.org\/10.1002\/1878-0261.12144","DOI":"10.1002\/1878-0261.12144"},{"issue":"4","key":"3675_CR12","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1200\/jco.2009.25.1496","volume":"28","author":"H Becker","year":"2010","unstructured":"Becker H, Marcucci G, Maharry K, Radmacher MD, Mr\u00f3zek K, Margeson D et al (2010) Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a cancer and leukemia group B study. J Clin Oncol 28(4):596\u2013604. https:\/\/doi.org\/10.1200\/jco.2009.25.1496","journal-title":"J Clin Oncol"},{"issue":"4","key":"3675_CR13","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3390\/cancers14041065","volume":"14","author":"L Bento","year":"2022","unstructured":"Bento L et al (2022) Screening for Prognostic microRNAs Associated with Treatment Failure in Diffuse Large B Cell Lymphoma. Cancers 14(4):1065","journal-title":"Cancers"},{"issue":"11","key":"3675_CR14","doi-asserted-by":"publisher","first-page":"679022","DOI":"10.3389\/fonc.2021.679022","volume":"11","author":"B Bhatnagar","year":"2021","unstructured":"Bhatnagar B, Garzon R (2021) Clinical applications of microRNAs in acute myeloid leukemia: a mini-review. Front Oncol 11(11):679022. https:\/\/doi.org\/10.3389\/fonc.2021.679022","journal-title":"Front Oncol"},{"issue":"10","key":"3675_CR15","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.3390\/ijms22105153","volume":"22","author":"E Bollaert","year":"2021","unstructured":"Bollaert E et al (2021) MiR-15a-5p confers chemoresistance in acute myeloid leukemia by inhibiting autophagy induced by daunorubicin. Int J Mol Sci 22(10):5153","journal-title":"Int J Mol Sci"},{"issue":"11","key":"3675_CR16","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrc1997","volume":"6","author":"GA Calin","year":"2006","unstructured":"Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6(11):857\u2013866. https:\/\/doi.org\/10.1038\/nrc1997","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"3675_CR17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1124\/jpet.122.001429","volume":"384","author":"J Carvajal-Moreno","year":"2023","unstructured":"Carvajal-Moreno J et al (2023) Effects of hsa-miR-9-3p and hsa-miR-9-5p on topoisomerase II\u03b2 expression in human leukemia K562 cells with acquired resistance to etoposide. J Pharmacol Exp Ther 384(2):265\u2013276","journal-title":"J Pharmacol Exp Ther"},{"issue":"28","key":"3675_CR18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jare.2020.08.012","volume":"1","author":"C Chakraborty","year":"2021","unstructured":"Chakraborty C, Sharma AR, Sharma G, Lee SS (2021) Therapeutic advances of miRNAs: a preclinical and clinical update. J Adv Res 1(28):127\u2013138","journal-title":"J Adv Res"},{"issue":"9","key":"3675_CR19","first-page":"4308","volume":"9","author":"D Chen","year":"2017","unstructured":"Chen D, Wu D, Shao K, Ye B, Huang J, Gao Y (2017) MiR-15a-5p negatively regulates cell survival and metastasis by targeting CXCL10 in chronic myeloid leukemia. Am J Transl Res 9(9):4308","journal-title":"Am J Transl Res"},{"issue":"1","key":"3675_CR20","first-page":"508","volume":"19","author":"X Chen","year":"2019","unstructured":"Chen X et al (2019) miR-1271-5p inhibits cell proliferation and induces apoptosis in acute myeloid leukemia by targeting ZIC2. Mol Med Rep 19(1):508\u2013514","journal-title":"Mol Med Rep"},{"issue":"19","key":"3675_CR21","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.3390\/molecules24193535","volume":"24","author":"IH Ciftci","year":"2019","unstructured":"Ciftci IH, Radwan OM, Ozturk ES, Ulusoy NG, Sozer E, Ellakwa ED, Ocak Z, Can MFS, Ali TI, Abd-Alla H et al (2019) Design, synthesis and biological evaluation of pentacyclic triterpene derivatives: optimization of anti-ABL kinase activity. Molecules 24(19):3535. https:\/\/doi.org\/10.3390\/molecules24193535","journal-title":"Molecules"},{"issue":"3","key":"3675_CR22","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/PPO.0b013e318258b60a","volume":"18","author":"CP Concepcion","year":"2012","unstructured":"Concepcion CP, Bonetti C, Ventura A (2012) The microRNA-17-92 family of microRNA clusters in development and disease. Cancer J 18(3):262\u2013267","journal-title":"Cancer J"},{"issue":"7","key":"3675_CR23","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1158\/0008-5472","volume":"74","author":"D de Leeuw","year":"2014","unstructured":"de Leeuw D, Denkers F, Olthof MC, Rutten AP, Pouwels W, Schuurhuis GJ et al (2014) Attenuation of microRNA-126 expression that drives CD34+38- stem\/progenitor cells in acute myeloid leukemia leads to tumor eradication. Cancer Res 74(7):2094\u20132105. https:\/\/doi.org\/10.1158\/0008-5472","journal-title":"Cancer Res"},{"issue":"6","key":"3675_CR24","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.tig.2022.02.006","volume":"38","author":"C Diener","year":"2022","unstructured":"Diener C, Keller A, Meese E (2022) Emerging concepts of miRNA therapeutics: from cells to clinic. Trends Genet 38(6):613\u2013626","journal-title":"Trends Genet"},{"issue":"6","key":"3675_CR25","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1139\/bcb-2018-0017","volume":"96","author":"Q Ding","year":"2018","unstructured":"Ding Q et al (2018) MicroRNA-126 attenuates cell apoptosis by targeting TRAF7 in acute myeloid leukemia cells. Biochem Cell Biol 96(6):840\u2013846","journal-title":"Biochem Cell Biol"},{"issue":"11","key":"3675_CR26","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1038\/leu.2015.139","volume":"29","author":"AM Dorrance","year":"2015","unstructured":"Dorrance AM, Neviani P, Ferenchak GJ, Huang X, Nicolet D, Maharry KS et al (2015) Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemia. Leukemia 29(11):2143\u20132153. https:\/\/doi.org\/10.1038\/leu.2015.139","journal-title":"Leukemia"},{"key":"3675_CR27","doi-asserted-by":"crossref","unstructured":"Ellakwa DES, Mushtaq N, Khan S, Jabbar A, Abdelmalek MA, Wadan AHS, ... Raza A (2024) Molecular functions of microRNAs in colorectal cancer: recent roles in proliferation, angiogenesis, apoptosis, and chemoresistance.\u00a0Naunyn-Schmiedeberg's Arch Pharmacol 1\u201314","DOI":"10.1007\/s00210-024-03076-w"},{"issue":"9","key":"3675_CR28","doi-asserted-by":"crossref","first-page":"e2371","DOI":"10.1038\/cddis.2016.256","volume":"7","author":"ZH Fang","year":"2016","unstructured":"Fang ZH et al (2016) miR-150 exerts antileukemia activity in vitro and in vivo through regulating genes in multiple pathways. Cell Death Dis 7(9):e2371","journal-title":"Cell Death Dis"},{"issue":"6","key":"3675_CR29","first-page":"1624","volume":"40","author":"LL Fang","year":"2017","unstructured":"Fang LL, Wang XH, Sun BF, Zhang XD, Zhu XH, Yu ZJ, Luo H (2017) Expression, regulation and mechanism of action of the miR-17-92 cluster in tumor cells. Int J Mol Med 40(6):1624\u20131630","journal-title":"Int J Mol Med"},{"issue":"3","key":"3675_CR30","doi-asserted-by":"crossref","first-page":"e32834","DOI":"10.1371\/journal.pone.0032834","volume":"7","author":"J Fei","year":"2012","unstructured":"Fei J et al (2012) miR-181a post-transcriptionally downregulates oncogenic RalA and contributes to growth inhibition and apoptosis in chronic myelogenous leukemia (CML). PLoS ONE 7(3):e32834","journal-title":"PLoS ONE"},{"issue":"2","key":"3675_CR31","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1158\/1078-0432.CCR-12-1922","volume":"19","author":"E Fonte","year":"2013","unstructured":"Fonte E et al (2013) In Vitro Sensitivity of CLL Cells to Fludarabine May Be Modulated by the Stimulation of Toll-like Receptors. Clin Cancer Res 19(2):367\u2013379","journal-title":"Clin Cancer Res"},{"key":"3675_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2017.03.021","volume":"616","author":"Y Gao","year":"2017","unstructured":"Gao Y, Lin L, Li T, Yang J, Wei Y (2017) The role of miRNA-223 in cancer: function, diagnosis and therapy. Gene 616:1\u20137. https:\/\/doi.org\/10.1016\/j.gene.2017.03.021","journal-title":"Gene"},{"issue":"6","key":"3675_CR33","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1182\/blood-2007-07-098749","volume":"111","author":"R Garzon","year":"2008","unstructured":"Garzon R, Volinia S, Liu CG, Fernandez-Cymering C, Palumbo T, Pichiorri F et al (2008) MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 111(6):3183\u20133189. https:\/\/doi.org\/10.1182\/blood-2007-07-098749","journal-title":"Blood"},{"issue":"26","key":"3675_CR34","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1182\/blood-2009-03-211938","volume":"114","author":"R Garzon","year":"2009","unstructured":"Garzon R et al (2009) MicroRNA 29b functions in acute myeloid leukemia. Blood 114(26):5331\u20135341","journal-title":"Blood"},{"issue":"3","key":"3675_CR35","doi-asserted-by":"crossref","first-page":"304","DOI":"10.6000\/2292-2598.2021.09.03.6","volume":"9","author":"F Ghiasi","year":"2021","unstructured":"Ghiasi F et al (2021) The effect of cognitive-behavioral therapy (CBT) on anxiety reduction in critical care unit (CCU) patients during hospitalization. J Intellect Disabl Diagn Treat 9(3):304\u201310","journal-title":"J Intellect Disabl Diagn Treat"},{"issue":"7","key":"3675_CR36","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.1002\/jcb.26800","volume":"119","author":"ES Ghodousi","year":"2018","unstructured":"Ghodousi ES, Rahgozar S (2018) MicroRNA-326 and microRNA-200c: two novel biomarkers for diagnosis and prognosis of pediatric acute lymphoblastic leukemia. J Cell Biochem 119(7):6024\u20136032","journal-title":"J Cell Biochem"},{"issue":"7","key":"3675_CR37","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3727\/096504016X14829256525028","volume":"25","author":"Y Gu","year":"2017","unstructured":"Gu Y et al (2017) miR-92a inhibits proliferation and induces apoptosis by regulating methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) expression in acute myeloid leukemia. Oncol Res 25(7):1069\u20131079","journal-title":"Oncol Res"},{"issue":"2","key":"3675_CR38","first-page":"1128","volume":"237","author":"K Gupta","year":"2022","unstructured":"Gupta K, Gupta S, Jha V (2022) MicroRNAs in acute myeloid leukemia: from diagnosis to therapy. J Cell Physiol 237(2):1128\u20131144","journal-title":"J Cell Physiol"},{"issue":"2","key":"3675_CR39","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/jim-2020-001563","volume":"69","author":"EM Habib","year":"2021","unstructured":"Habib EM et al (2021) Circulating miR-146a expression predicts early treatment response to imatinib in adult chronic myeloid leukemia. J Investig Med 69(2):333\u2013337","journal-title":"J Investig Med"},{"issue":"8","key":"3675_CR40","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/s41419-018-0837-x","volume":"9","author":"JU Hartmann","year":"2018","unstructured":"Hartmann JU et al (2018) MicroRNA-143 targets ERK5 in granulopoiesis and predicts outcome of patients with acute myeloid leukemia. Cell Death Dis 9(8):814","journal-title":"Cell Death Dis"},{"key":"3675_CR41","doi-asserted-by":"publisher","first-page":"106568","DOI":"10.1016\/j.phrs.2022.106568","volume":"187","author":"M Hashemi","year":"2022","unstructured":"Hashemi M, Mirdamadi MSA, Talebi Y, Khaniabad N, Banaei G, Daneii P, Gholami S, Ghorbani A, Tavakolpournegari A, Farsani ZM, Zarrabi A, Nabavi N, Zandieh MA, Rashidi M, Taheriazam A, Entezari M, Khan H (2022) Pre-clinical and clinical importance of miR-21 in human cancers: tumorigenesis, therapy response, delivery approaches and targeting agents. Pharmacol Res 187:106568. https:\/\/doi.org\/10.1016\/j.phrs.2022.106568","journal-title":"Pharmacol Res"},{"issue":"7","key":"3675_CR42","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/iub.2273","volume":"72","author":"Y Hu","year":"2020","unstructured":"Hu Y et al (2020) MicroRNA-34a-mediated death of acute myeloid leukemia stem cells through apoptosis induction and exosome shedding inhibition via histone deacetylase 2 targeting. IUBMB Life 72(7):1481\u20131490","journal-title":"IUBMB Life"},{"issue":"6","key":"3675_CR43","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.molcel.2009.09.006","volume":"35","author":"X Huang","year":"2009","unstructured":"Huang X, Ding L, Bennewith KL, Tong RT, Welford SM, Ang KK, Story M, Le Q-T, Giaccia AJ (2009) Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. Mol Cell 35(6):856\u2013867. https:\/\/doi.org\/10.1016\/j.molcel.2009.09.006","journal-title":"Mol Cell"},{"issue":"9","key":"3675_CR44","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1158\/1078-0432.Ccr-12-3191","volume":"19","author":"X Huang","year":"2013","unstructured":"Huang X, Schwind S, Yu B, Santhanam R, Wang H, Hoellerbauer P et al (2013) Targeted delivery of microRNA-29 B by transferrin-conjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemia. Clin Cancer Res 19(9):2355\u20132367. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-12-3191","journal-title":"Clin Cancer Res"},{"issue":"2","key":"3675_CR45","first-page":"418","volume":"30","author":"HM Huang","year":"2022","unstructured":"Huang HM et al (2022) Mechanism of miR-155 promoting drug resistance in childhood acute lymphoblastic leukemia by regulating Wnt\/\u03b2-catenin signaling pathway. Zhongguo Shi Yan Xue Ye Xue Za Zhi 30(2):418\u2013424","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"9","key":"3675_CR46","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/s10038-021-00938-6","volume":"66","author":"J Inoue","year":"2021","unstructured":"Inoue J, Inazawa J (2021) Cancer-associated miRNAs and their therapeutic potential. J Hum Genet 66(9):937\u2013945. https:\/\/doi.org\/10.1038\/s10038-021-00938-6","journal-title":"J Hum Genet"},{"issue":"7","key":"3675_CR47","first-page":"1137","volume":"125","author":"J Iqbal","year":"2015","unstructured":"Iqbal J et al (2015) Global microRNA Expression Profiling Uncovers Molecular Markers for Classification and Prognosis in Aggressive B-Cell Lymphoma. Blood J Am Soc Hematol 125(7):1137\u20131145","journal-title":"Blood J Am Soc Hematol"},{"issue":"6","key":"3675_CR48","doi-asserted-by":"crossref","first-page":"907","DOI":"10.4149\/neo_2018_180121N44","volume":"65","author":"T Jiang","year":"2018","unstructured":"Jiang T et al (2018) miR-451a induced apoptosis of Philadelphia chromosome-positive acute lymphoblastic leukemia cells by targeting IL-6R. Neoplasma 65(6):907\u2013914","journal-title":"Neoplasma"},{"key":"3675_CR49","doi-asserted-by":"crossref","first-page":"147806","DOI":"10.1016\/j.gene.2023.147806","volume":"889","author":"W Jiang","year":"2023","unstructured":"Jiang W et al (2023) miR-125b-5p-MAPK1-C\/EBP\u03b1 feedback loop regulates all-trans retinoic acid resistance in acute promyelocytic leukemia. Gene 889:147806","journal-title":"Gene"},{"key":"3675_CR50","doi-asserted-by":"publisher","unstructured":"Jiang X, Huang H, Li Z, Li Y, Wang X, Gurbuxani S, Chen P, He C, You D, Zhang S, Wang J, Elkahloun A, Price C, Hong G, Ren H, Rejani B, Neilly MB, Matthews J, Xu M, \u2026 Chen J (2013) NIH Public Access. 22(4):524\u2013535. https:\/\/doi.org\/10.1016\/j.ccr.2012.08.028.Blockade","DOI":"10.1016\/j.ccr.2012.08.028.Blockade"},{"key":"3675_CR51","doi-asserted-by":"publisher","unstructured":"Jiang X et al (2019) MicroRNA-221 sensitizes chronic myeloid leukemia cells to imatinib by targeting STAT5. Leukemia & Lymphoma. https:\/\/doi.org\/10.1080\/10428194.2018.1543875","DOI":"10.1080\/10428194.2018.1543875"},{"issue":"3","key":"3675_CR52","first-page":"245","volume":"15","author":"A Johnson","year":"2020","unstructured":"Johnson A (2020) MicroRNAs as biomarkers in leukemia: current status and prospects. J Hematol Res 15(3):245\u2013260","journal-title":"J Hematol Res"},{"issue":"9","key":"3675_CR53","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.trecan.2024.06.006","volume":"10","author":"A Jurj","year":"2024","unstructured":"Jurj A, Fontana B, Varani G, Calin GA (2024) Small molecules targeting microRNAs: new opportunities and challenges in precision cancer therapy. Trends Cancer 10(9):809\u2013824","journal-title":"Trends Cancer"},{"issue":"1","key":"3675_CR54","first-page":"383","volume":"77","author":"M Kadhem Mallakh","year":"2022","unstructured":"Kadhem Mallakh M, Mohammed Mahmood M, Hasan Mohammed Ali S (2022) Immunomolecular investigation of human papillomavirus genotypes (16, 18) and P63 expression in patients with malignant and non-malignant colorectal tumors. Arch Razi Inst 77(1):383\u2013390","journal-title":"Arch Razi Inst"},{"issue":"10","key":"3675_CR55","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1038\/leu.2015.106","volume":"29","author":"J Khalife","year":"2015","unstructured":"Khalife J, Radomska HS, Santhanam R, Huang X, Neviani P, Saultz J et al (2015) Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia. Leukemia 29(10):1981\u20131992. https:\/\/doi.org\/10.1038\/leu.2015.106","journal-title":"Leukemia"},{"key":"3675_CR56","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1038\/s12276-023-01050-9","volume":"55","author":"T Kim","year":"2023","unstructured":"Kim T, Croce CM (2023) MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies. Exp Mol Med 55:1314\u20131321. https:\/\/doi.org\/10.1038\/s12276-023-01050-9","journal-title":"Exp Mol Med"},{"key":"3675_CR57","doi-asserted-by":"crossref","unstructured":"Kong W, He L, Richards EJ, Challa S, Xu CX, Permuth-Wey J, ... Cheng JQ (2014) Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer.\u00a0Oncogene\u00a033(6):679\u2013689","DOI":"10.1038\/onc.2012.636"},{"issue":"7","key":"3675_CR58","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/10245332.2017.1292204","volume":"22","author":"HA Labib","year":"2017","unstructured":"Labib HA et al (2017) Upregulation of microRNA-21 is a poor prognostic marker in patients with childhood B cell acute lymphoblastic leukemia. Hematology 22(7):392\u2013397","journal-title":"Hematology"},{"key":"3675_CR59","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/jcar.JCar_27_20","volume":"20","author":"F Lalfamkima","year":"2021","unstructured":"Lalfamkima F et al (2021) Clinical diagnostic criteria versus advanced imaging in prediction of cervical lymph node metastasis in oral squamous cell carcinomas: a magnetic resonance imaging based study. J Carcinog 20:3","journal-title":"J Carcinog"},{"issue":"2","key":"3675_CR60","first-page":"112","volume":"8","author":"S Lee","year":"2019","unstructured":"Lee S, Garcia R (2019) Stability of miRNAs in biological fluids: implications for disease monitoring. Biomark Med 8(2):112\u2013125","journal-title":"Biomark Med"},{"issue":"4","key":"3675_CR61","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.3892\/or.2017.5464","volume":"37","author":"Y Li","year":"2017","unstructured":"Li Y et al (2017) miR-9 regulates the multidrug resistance of chronic myelogenous leukemia by targeting ABCB1. Oncol Rep 37(4):2193\u20132200","journal-title":"Oncol Rep"},{"issue":"3","key":"3675_CR62","first-page":"2771","volume":"18","author":"G Li","year":"2018","unstructured":"Li G et al (2018) Downregulation of microRNA-21 expression inhibits proliferation, and induces G1 arrest and apoptosis via the PTEN\/AKT pathway in SKM-1 cells. Mol Med Rep 18(3):2771\u20132779","journal-title":"Mol Med Rep"},{"issue":"1","key":"3675_CR63","first-page":"5613417","volume":"2019","author":"Y Li","year":"2019","unstructured":"Li Y, Zhang G, Wu B, Yang W, Liu Z (2019b) miR-199a-5p represses protective autophagy and overcomes chemoresistance by directly targeting DRAM1 in acute myeloid leukemia. Journal of Oncology 2019(1):5613417","journal-title":"Journal of Oncology"},{"issue":"2","key":"3675_CR64","first-page":"436","volume":"28","author":"S-W Li","year":"2020","unstructured":"Li S-W et al (2020) Expression and clinical significance of miR-146a and miR-221 in childhood acute T lymphoblastic leukemia. Zhongguo shi yan xue ye xue za zhi 28(2):436\u2013441","journal-title":"Zhongguo shi yan xue ye xue za zhi"},{"key":"3675_CR65","doi-asserted-by":"crossref","unstructured":"Li C, Yan H, Yin J, Ma J, Liao A, Yang S, ... Wang L (2019) MicroRNA-21 promotes proliferation in acute myeloid leukemia by targeting Kr\u00fcppel-like factor 5.\u00a0Oncol Lett\u00a018(3):3367\u20133372","DOI":"10.3892\/ol.2019.10667"},{"issue":"3","key":"3675_CR66","first-page":"658","volume":"32","author":"B Liang","year":"2024","unstructured":"Liang B et al (2024) Effect of TLK2 expression regulated by MiR-21 on proliferation and apoptosis of acute myeloid leukemia cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi 32(3):658\u2013662","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"3675_CR67","doi-asserted-by":"crossref","unstructured":"Liang C, Li Y, Wang LN, Zhang XL, Luo JS, Peng CJ, ... Luo XQ (2021) Up-regulated miR-155 is associated with poor prognosis in childhood acute lymphoblastic leukemia and promotes cell proliferation targeting ZNF238. Hematology 26(1):16\u201325","DOI":"10.1080\/16078454.2020.1860187"},{"issue":"2","key":"3675_CR68","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.18632\/oncotarget.12343","volume":"8","author":"Q Liao","year":"2017","unstructured":"Liao Q, Wang B, Li X, Jiang G (2017) miRNAs in acute myeloid leukemia. Oncotarget 8(2):3666\u20133682","journal-title":"Oncotarget"},{"issue":"1","key":"3675_CR69","doi-asserted-by":"crossref","first-page":"7704","DOI":"10.1080\/21655979.2021.1982310","volume":"12","author":"W Liu","year":"2021","unstructured":"Liu W, Cheng F (2021) Circular RNA circCRKL inhibits the proliferation of acute myeloid leukemia cells via the miR-196a-5p\/miR-196b-5p\/p27 axis. Bioengineered 12(1):7704\u20137713","journal-title":"Bioengineered"},{"key":"3675_CR70","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mcp.2019.02.001","volume":"44","author":"H Liu","year":"2019","unstructured":"Liu H et al (2019a) MiR-486-5p inhibits the proliferation of leukemia cells and induces apoptosis through targeting FOXO1. Mol Cell Probes 44:37\u201343","journal-title":"Mol Cell Probes"},{"issue":"3","key":"3675_CR71","doi-asserted-by":"crossref","first-page":"579","DOI":"10.7150\/ijbs.29775","volume":"15","author":"Y Liu","year":"2019","unstructured":"Liu Y, Lei P, Qiao H, Sun K, Lu X, Bao F, Yu R, Lian C, Li Y, Chen W, Xue F (2019b) miR-9 enhances the chemosensitivity of AML cells to daunorubicin by targeting the EIF5A2\/MCL-1 axis. Int J Biol Sci 15(3):579","journal-title":"Int J Biol Sci"},{"key":"3675_CR72","doi-asserted-by":"publisher","unstructured":"Liu L, Chen R, Zhang Y, Fan W, Xiao F, Yan X (2015) Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemia. Diagn Pathol 1\u20137. https:\/\/doi.org\/10.1186\/s13000-015-0345-6","DOI":"10.1186\/s13000-015-0345-6"},{"key":"3675_CR73","doi-asserted-by":"crossref","unstructured":"Lyu X, Li J, Yun X, Huang R, Deng X, Wang Y, ... Xiao G (2017) miR-181a-5p, an inducer of Wnt-signaling, facilitates cell proliferation in acute lymphoblastic leukemia.\u00a0Oncol Rep 37(3):1469\u20131476","DOI":"10.3892\/or.2017.5425"},{"key":"3675_CR74","doi-asserted-by":"crossref","first-page":"108623","DOI":"10.1016\/j.biopha.2019.108623","volume":"112","author":"J Ma","year":"2019","unstructured":"Ma J et al (2019) MiR-378 promoted cell proliferation and inhibited apoptosis by enhanced stem cell properties in chronic myeloid leukemia K562 cells. Biomed Pharmacother 112:108623","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"3675_CR75","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2174\/138920210793175895","volume":"11","author":"L Macfarlane","year":"2010","unstructured":"Macfarlane L, Murphy PR (2010) MicroRNA: biogenesis, function and role in cancer. Curr Genomics 11(7):537\u2013561","journal-title":"Curr Genomics"},{"issue":"17","key":"3675_CR76","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1200\/jco.2012.45.6228","volume":"31","author":"G Marcucci","year":"2013","unstructured":"Marcucci G, Maharry KS, Metzeler KH, Volinia S, Wu YZ, Mr\u00f3zek K et al (2013) Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients. J Clin Oncol 31(17):2086\u20132093. https:\/\/doi.org\/10.1200\/jco.2012.45.6228","journal-title":"J Clin Oncol"},{"issue":"6","key":"3675_CR77","doi-asserted-by":"publisher","first-page":"8465","DOI":"10.1002\/jcp.27776","volume":"234","author":"R Mardani","year":"2019","unstructured":"Mardani R (2019) MicroRNA in leukemia: tumor suppressors and oncogenes with prognostic potential. J Cell Physiol 234(6):8465\u20138486. https:\/\/doi.org\/10.1002\/jcp.27776. (October 2018)","journal-title":"J Cell Physiol"},{"key":"3675_CR78","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/s41388-024-03076-3","volume":"43","author":"GAD Metcalf","year":"2024","unstructured":"Metcalf GAD (2024) MicroRNAs: circulating biomarkers for the early detection of imperceptible cancers via biosensor and machine-learning advances. Oncogene 43:2135\u20132142. https:\/\/doi.org\/10.1038\/s41388-024-03076-3","journal-title":"Oncogene"},{"key":"3675_CR79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-021-01578-8","volume":"38","author":"S Najjary","year":"2021","unstructured":"Najjary S et al (2021) Combination therapy with miR-34a and doxorubicin synergistically induced apoptosis in T-cell acute lymphoblastic leukemia cell line. Med Oncol 38:1\u201310","journal-title":"Med Oncol"},{"issue":"8","key":"3675_CR80","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.3390\/cancers13081839","volume":"13","author":"J Navarro-Barriuso","year":"2021","unstructured":"Navarro-Barriuso J, Hern\u00e1ndez-Sierra A, Espinosa-Parrilla Y (2021) Prognostic and predictive microRNAs in acute myeloid leukemia: a systematic review and meta-analysis. Cancers 13(8):1839","journal-title":"Cancers"},{"key":"3675_CR81","doi-asserted-by":"publisher","unstructured":"Neaga A, Bagacean C, Tempescul A, Jimbu L, Mesaros O, Blag C, Tomuleasa C, Bocsan C, Gaman M (2021) MicroRNAs associated with a good prognosis of acute myeloid leukemia and their effect on macrophage polarization. 11(January):1\u201314https:\/\/doi.org\/10.3389\/fimmu.2020.582915","DOI":"10.3389\/fimmu.2020.582915"},{"issue":"4","key":"3675_CR82","doi-asserted-by":"crossref","first-page":"BSR20190150","DOI":"10.1042\/BSR20190150","volume":"39","author":"ZY Nie","year":"2019","unstructured":"Nie ZY et al (2019) miR-140\u20135p induces cell apoptosis and decreases Warburg effect in chronic myeloid leukemia by targeting SIX1. Biosci Rep 39(4):BSR20190150","journal-title":"Biosci Rep"},{"key":"3675_CR83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.20517\/2347-8659.2017.68","volume":"5","author":"MJ Qu","year":"2018","unstructured":"Qu MJ, Pan JJ, Shi XJ, Zhang ZJ, Tang YH, Yang GY (2018) MicroRNA-126 is a prospective target for vascular. Neuroimmunol Neuroinflammation 5:1\u20137","journal-title":"Neuroimmunol Neuroinflammation"},{"key":"3675_CR84","doi-asserted-by":"crossref","first-page":"100023","DOI":"10.1016\/j.amolm.2023.100023","volume":"13","author":"A Quattrocchi","year":"2023","unstructured":"Quattrocchi A, Cappelli LV, De Simone G, De Marinis E, Gentile M, Gasperi T, Pulsoni A, Ascenzi P, Nervi C (2023) Biomarkers in acute myeloid leukemia: from state of the art in risk classification to future challenges of RNA editing as disease predictor and therapy target. Aspects Mol Med 13:100023","journal-title":"Aspects Mol Med"},{"issue":"22","key":"3675_CR85","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1182\/bloodV128.22.1829.1829","volume":"128","author":"C Querfeld","year":"2016","unstructured":"Querfeld C, Pacheco T, Foss FM, Halwani AS, Porcu P, Seto AG et al (2016) Preliminary results of a phase 1 trial evaluating MRG-106, a synthetic microRNA antagonist (LNA antimir) of microRNA-155, in patients with CTCL. Blood 128(22):1829. https:\/\/doi.org\/10.1182\/bloodV128.22.1829.1829","journal-title":"Blood"},{"key":"3675_CR86","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4103\/jcar.jcar_14_21","volume":"20","author":"S Rao","year":"2021","unstructured":"Rao S et al (2021) Molecular characterization of lung carcinomas: a study on diagnostic, predictive, and prognostic markers using immunohistochemical analysis at a Tertiary Care Center in Uttarakhand. India J Carcinog 20:17","journal-title":"India J Carcinog"},{"key":"3675_CR87","doi-asserted-by":"publisher","unstructured":"Raza A, Fatima P, Yasmeen B et al (2024) From resistance to remedy: the role of clustered regularly interspaced short palindromic repeats system in combating antimicrobial resistance\u2014a review. Naunyn-Schmiedeberg\u2019s Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-024-03509-6","DOI":"10.1007\/s00210-024-03509-6"},{"key":"3675_CR88","first-page":"102","volume":"45","author":"M Rodriguez","year":"2023","unstructured":"Rodriguez M, Thompson K, Brown L (2023) Integrating miRNA-based prognostic markers in leukemia management: a comprehensive review. Leuk Res 45:102\u2013115","journal-title":"Leuk Res"},{"issue":"2","key":"3675_CR89","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1097\/MPH.0000000000002168","volume":"44","author":"F Said","year":"2022","unstructured":"Said F et al (2022) Clinical significance of MicroRNA-29a and MicroRNA-100 gene expression in pediatric acute myeloid leukemia. J Pediatr Hematol Oncol 44(2):e391\u2013e395","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"3675_CR90","first-page":"708","volume":"42","author":"N Sakurai","year":"2019","unstructured":"Sakurai N et al (2019) Role of microRNAs in Glucocorticoid-Resistant B-Cell Precursor Acute Lymphoblastic Leukemia. Oncol Rep 42(2):708\u2013716","journal-title":"Oncol Rep"},{"issue":"5","key":"3675_CR91","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1182\/blood-2011-05-351510","volume":"119","author":"D Sampath","year":"2012","unstructured":"Sampath D, Liu C, Vasan K, Sulda M, Puduvalli VK, Wierda WG, Keating MJ (2012) Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia. Blood 119(5):1162\u20131172. https:\/\/doi.org\/10.1182\/blood-2011-05-351510","journal-title":"Blood"},{"issue":"9","key":"3675_CR92","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.3390\/ijms23094657","volume":"23","author":"Y Sbirkov","year":"2022","unstructured":"Sbirkov Y, Vergov B, Mehterov N, Sarafian V (2022) miRNAs in lymphocytic leukemias\u2014the miRror of drug resistance. Int J Mol Sci 23(9):4657","journal-title":"Int J Mol Sci"},{"issue":"5","key":"3675_CR93","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3324\/haematol.2010.026138","volume":"96","author":"D Schotte","year":"2011","unstructured":"Schotte D et al (2011) MicroRNA Characterize Genetic Diversity and Drug Resistance in Pediatric Acute Lymphoblastic Leukemia. Haematologica 96(5):703","journal-title":"Haematologica"},{"issue":"36","key":"3675_CR94","doi-asserted-by":"publisher","first-page":"5257","DOI":"10.1200\/jco.2010.29.2953","volume":"28","author":"S Schwind","year":"2010","unstructured":"Schwind S, Maharry K, Radmacher MD, Mr\u00f3zek K, Holland KB, Margeson D et al (2010) Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study. J Clin Oncol 28(36):5257\u20135264. https:\/\/doi.org\/10.1200\/jco.2010.29.2953","journal-title":"J Clin Oncol"},{"key":"3675_CR95","doi-asserted-by":"publisher","unstructured":"Shaaban EM, Ellakwa DE, Elaraby NM, Amr KS, Mohamadin AM (2022) The effect of insulin-loaded gold and carboxymethyl chitosan nanoparticles on gene expression of glucokinase and pyruvate kinase in rats with diabetes type 1. J Food Biochem 46(12):e14447. https:\/\/doi.org\/10.1111\/jfbc.14447","DOI":"10.1111\/jfbc.14447"},{"issue":"4","key":"3675_CR96","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41408-021-00473-9","volume":"11","author":"J Smith","year":"2021","unstructured":"Smith J, Davis E, Wilson T (2021) MicroRNAs in minimal residual disease detection for leukemia. Blood Cancer J 11(4):78\u201390","journal-title":"Blood Cancer J"},{"issue":"8","key":"3675_CR97","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3727\/096504019X15555388198071","volume":"27","author":"H Sun","year":"2019","unstructured":"Sun H et al (2019) NET1 enhances proliferation and chemoresistance in acute lymphoblastic leukemia cells. Oncol Res 27(8):935","journal-title":"Oncol Res"},{"issue":"4","key":"3675_CR98","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.bbrc.2019.11.156","volume":"522","author":"Y Sun","year":"2020","unstructured":"Sun Y, Wang H, Luo C (2020) MiR-100 regulates cell viability and apoptosis by targeting ATM in pediatric acute myeloid leukemia. Biochem Biophys Res Commun 522(4):855\u2013861","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"3675_CR99","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41374-021-00638-x","volume":"102","author":"X Sun","year":"2022","unstructured":"Sun X, Guan G, Dai Y, Zhao P, Liu L, Wang Q, Li X (2022) microRNA-155-5p initiates childhood acute lymphoblastic leukemia by regulating the IRF4\/CDK6\/CBL axis. Lab Invest 102(4):411\u2013421","journal-title":"Lab Invest"},{"key":"3675_CR100","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.12659\/MSM.894812","volume":"21","author":"X Tang","year":"2015","unstructured":"Tang X, Chen L, Yan X, Li Y, Xiong Y, Zhou X (2015) Overexpression of miR-210 is associated with poor prognosis of acute myeloid leukemia. Med Sci Monit 21:3427","journal-title":"Med Sci Monit"},{"key":"3675_CR101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-020-01646-5","volume":"21","author":"Y Tang","year":"2021","unstructured":"Tang Y, Zong S, Zeng H, Ruan X, Yao L, Han S, Hou F (2021) MicroRNAs and angiogenesis: a new era for the management of colorectal cancer. Cancer Cell Int 21:1\u201311","journal-title":"Cancer Cell Int"},{"issue":"1","key":"3675_CR102","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1186\/s12885-022-09996-1","volume":"22","author":"YJ Tang","year":"2022","unstructured":"Tang YJ et al (2022) miR-29b-3p suppresses the malignant biological behaviors of AML cells via inhibiting NF-\u03baB and JAK\/STAT signaling pathways by targeting HuR. BMC Cancer 22(1):909","journal-title":"BMC Cancer"},{"issue":"5","key":"3675_CR103","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrendo.2018.18","volume":"18","author":"P Taylor","year":"2021","unstructured":"Taylor P (2021) The future of personalized care in leukemia: role of miRNA prognostic markers. Nat Rev Clin Oncol 18(5):301\u2013315","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"3675_CR104","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ygyno.2008.04.033","volume":"110","author":"DD Taylor","year":"2008","unstructured":"Taylor DD, Gercel-Taylor C (2008) MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 110(1):13\u201321. https:\/\/doi.org\/10.1016\/j.ygyno.2008.04.033","journal-title":"Gynecol Oncol"},{"issue":"6","key":"3675_CR105","doi-asserted-by":"crossref","first-page":"7461","DOI":"10.1007\/s13277-015-4581-x","volume":"37","author":"C Tian","year":"2016","unstructured":"Tian C et al (2016) MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1. Tumour Biol 37(6):7461\u20137471","journal-title":"Tumour Biol"},{"issue":"2","key":"3675_CR106","doi-asserted-by":"crossref","first-page":"11898","DOI":"10.1080\/21655979.2021.1999552","volume":"12","author":"H Tian","year":"2021","unstructured":"Tian H, Qiang T, Wang J, Ji L, Li B (2021) Simvastatin regulates the proliferation, apoptosis, migration and invasion of human acute myeloid leukemia cells via miR-19a-3p\/HIF-1\u03b1 axis. Bioengineered 12(2):11898\u201311908","journal-title":"Bioengineered"},{"issue":"2","key":"3675_CR107","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3390\/cancers14020264","volume":"14","author":"Pierce T TseJ","year":"2022","unstructured":"TseJ Pierce T, Carli EAL, Alorro MG, Thiem S, Marcusson EG, Ernst M, Buchert M (2022) Onco-miR-21 promotes Stat3-dependent gastric cancer progression. Cancers 14(2):264. https:\/\/doi.org\/10.3390\/cancers14020264","journal-title":"Cancers"},{"issue":"7","key":"3675_CR108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms23073469","volume":"23","author":"A Turk","year":"2022","unstructured":"Turk A, Calin GA, Kunej T (2022) MicroRNAs in leukemias\u202f: a clinically annotated compendium. Int J Mol Sci 23(7):1\u201316","journal-title":"Int J Mol Sci"},{"issue":"7","key":"3675_CR109","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.3390\/ijms23073469","volume":"23","author":"A Turk","year":"2022","unstructured":"Turk A, Calin GA, Kunej T (2022b) MicroRNAs in leukemias: a clinically annotated compendium. Int J Mol Sci 23(7):3469","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3675_CR110","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.leukres.2013.12.021","volume":"38","author":"ML Ufkin","year":"2014","unstructured":"Ufkin ML et al (2014) miR-125a regulates cell cycle, proliferation, and apoptosis by targeting the ErbB pathway in acute myeloid leukemia. Leuk Res 38(3):402\u2013410","journal-title":"Leuk Res"},{"issue":"1","key":"3675_CR111","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/jcmm.16110","volume":"25","author":"V Vandewalle","year":"2021","unstructured":"Vandewalle V et al (2021) miR-15a-5p and miR-21-5p contribute to chemoresistance in cytogenetically normal acute myeloid leukaemia by targeting PDCD4, ARL2 and BTG2. J Cell Mol Med 25(1):575\u2013585","journal-title":"J Cell Mol Med"},{"issue":"5","key":"3675_CR112","first-page":"1895","volume":"77","author":"GMA Wadai","year":"2022","unstructured":"Wadai GMA (2022) Evaluation of serum interleukin-15 in acute lymphoid and myeloid leukemia patients. Arch Razi Inst 77(5):1895\u20131899","journal-title":"Arch Razi Inst"},{"issue":"3","key":"3675_CR113","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.cellsig.2014.12.003","volume":"27","author":"X Wang","year":"2015","unstructured":"Wang X, Li J, Dong K, Lin F, Long M, Ouyang Y, Wei J, Chen X, Weng Y, He T, Zhang H (2015a) Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia. Cell Signal 27(3):443\u2013452. https:\/\/doi.org\/10.1016\/j.cellsig.2014.12.003","journal-title":"Cell Signal"},{"issue":"42","key":"3675_CR114","doi-asserted-by":"crossref","first-page":"44422","DOI":"10.18632\/oncotarget.6251","volume":"6","author":"LQ Wang","year":"2015","unstructured":"Wang LQ et al (2015b) Epigenetic silencing of tumor suppressor miR-3151 contributes to Chinese chronic lymphocytic leukemia by constitutive activation of MADD\/ERK and PIK3R2\/AKT signaling pathways. Oncotarget 6(42):44422\u201344436","journal-title":"Oncotarget"},{"issue":"1","key":"3675_CR115","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bbrc.2017.05.007","volume":"488","author":"Y Wang","year":"2017","unstructured":"Wang Y et al (2017) Overexpression of microRNA-125b inhibits human acute myeloid leukemia cells invasion, proliferation and promotes cells apoptosis by targeting NF-\u03baB signaling pathway. Biochem Biophys Res Commun 488(1):60\u201366","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"3675_CR116","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3727\/096504019X15528367532612","volume":"27","author":"Z Wang","year":"2019","unstructured":"Wang Z et al (2019) MicroRNA-204 potentiates the sensitivity of acute myeloid leukemia cells to arsenic trioxide. Oncol Res 27(9):1035","journal-title":"Oncol Res"},{"issue":"10","key":"3675_CR117","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1002\/cbin.11408","volume":"44","author":"X Wang","year":"2020","unstructured":"Wang X et al (2020b) miR-582-5p serves as an antioncogenic biomarker in intermediate risk AML with normal cytogenetics and could inhibit proliferation and induce apoptosis of leukemia cells. Cell Biol Int 44(10):2021\u20132030","journal-title":"Cell Biol Int"},{"key":"3675_CR118","doi-asserted-by":"crossref","unstructured":"Wang H, Wang L, Zhou X, Luo X, Liu K, Jiang E, ... Shang Z (2020) OSCC exosomes regulate miR\u2010210\u20103p targeting EFNA3 to promote oral cancer angiogenesis through the PI3K\/AKT pathway. BioMed Res Int 2020(1):2125656","DOI":"10.1155\/2020\/2125656"},{"key":"3675_CR119","doi-asserted-by":"publisher","first-page":"7546","DOI":"10.1038\/srep07546","volume":"4","author":"Y Wei","year":"2014","unstructured":"Wei Y, Yang J, Yi L, Wang Y, Dong Z, Liu Z, Ou-Yang S, Wu H, Zhong Z, Yin Z et al (2014) MiR-223-3p targeting SEPT6 promotes the biological behavior of prostate cancer. Sci Rep 4:7546. https:\/\/doi.org\/10.1038\/srep07546","journal-title":"Sci Rep"},{"issue":"2","key":"3675_CR120","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.21037\/tcr-20-3490","volume":"10","author":"Z Wei","year":"2021","unstructured":"Wei Z, Wang W, Li Q, Du L, He X (2021) The microRNA miR-19a-3p suppresses cell growth, migration, and invasion in multiple myeloma via the Wnt\/\u03b2-catenin pathway. Transl Cancer Res 10(2):1053","journal-title":"Transl Cancer Res"},{"issue":"7","key":"3675_CR121","first-page":"1789","volume":"36","author":"R Wilson","year":"2022","unstructured":"Wilson R, Anderson B, Chen Y (2022) Plasma miRNA patterns predict relapse in acute myeloid leukemia. Leukemia 36(7):1789\u20131801","journal-title":"Leukemia"},{"issue":"4","key":"3675_CR122","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1080\/15548627.2019.1635380","volume":"16","author":"H Wu","year":"2020","unstructured":"Wu H et al (2020) MIR145\u20133p promotes autophagy and enhances bortezomib sensitivity in multiple myeloma by targeting HDAC4. Autophagy 16(4):683\u2013697","journal-title":"Autophagy"},{"issue":"6","key":"3675_CR123","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.3892\/ol.2017.6076","volume":"13","author":"Y Xiao","year":"2017","unstructured":"Xiao Y et al (2017) MicroRNA 217 inhibits cell proliferation and enhances chemosensitivity to doxorubicin in acute myeloid leukemia by targeting KRAS. Oncol Lett 13(6):4986\u20134994","journal-title":"Oncol Lett"},{"issue":"3","key":"3675_CR124","first-page":"3287","volume":"17","author":"Y Xiao","year":"2019","unstructured":"Xiao Y, Su C, Deng T (2019) miR-223 decreases cell proliferation and enhances cell apoptosis in acute myeloid leukemia via targeting FBXW7. Oncol Lett 17(3):3287\u20133292","journal-title":"Oncol Lett"},{"issue":"1","key":"3675_CR125","first-page":"1134","volume":"18","author":"H Xu","year":"2018","unstructured":"Xu H, Wen Q (2018) Downregulation of miR-135a predicts poor prognosis in acute myeloid leukemia and regulates leukemia progression via modulating HOXA10 expression. Mol Med Rep 18(1):1134\u20131140","journal-title":"Mol Med Rep"},{"issue":"3","key":"3675_CR126","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ymthe.2019.01.012","volume":"27","author":"J Xu","year":"2019","unstructured":"Xu J et al (2019) miR-221\/222-mediated inhibition of autophagy promotes dexamethasone resistance in multiple myeloma. Mol Ther 27(3):559\u2013570","journal-title":"Mol Ther"},{"issue":"1","key":"3675_CR127","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12885-019-5315-z","volume":"19","author":"Y Xue","year":"2019","unstructured":"Xue Y, Ge Y, Kang M, Wu C, Wang Y, Rong L et al (2019) Selection of three miRNA signatures with prognostic value in non-M3 acute myeloid leukemia. BMC Cancer 19(1):109. https:\/\/doi.org\/10.1186\/s12885-019-5315-z","journal-title":"BMC Cancer"},{"key":"3675_CR128","first-page":"1","volume":"15","author":"CH Yeh","year":"2016","unstructured":"Yeh CH, Moles R, Nicot C (2016) Clinical significance of microRNAs in chronic and acute human leukemia. Mol Cancer 15:1\u201316","journal-title":"Mol Cancer"},{"key":"3675_CR129","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.exphem.2021.08.010","volume":"103","author":"J Yuan","year":"2021","unstructured":"Yuan J et al (2021) miRNA-223\u20133p modulates ibrutinib resistance through regulation of the CHUK\/Nf-\u03bab signaling pathway in mantle cell lymphoma. Exp Hematol 103:52-59.e2","journal-title":"Exp Hematol"},{"key":"3675_CR130","doi-asserted-by":"crossref","first-page":"106643","DOI":"10.1016\/j.leukres.2021.106643","volume":"109","author":"A Zamani","year":"2021","unstructured":"Zamani A et al (2021) miR-324\u20133p and miR-508\u20135p expression levels could serve as potential diagnostic and multidrug-resistant biomarkers in childhood acute lymphoblastic leukemia. Leuk Res 109:106643","journal-title":"Leuk Res"},{"key":"3675_CR131","doi-asserted-by":"crossref","unstructured":"Zeyt\u00fcn E, Alt\u0131ntop MD, Sever B, \u00d6zdemir A, Ellakwa DE, Ocak Z, ... Radwan MO (2021) A new series of antileukemic agents: design, synthesis, in vitro and in silico evaluation of thiazole-based ABL1 kinase inhibitors. Anti-Cancer Agents Med Chem (Formerly Current Medicinal Chemistry-Anti-Cancer Agents) 21(9):1099\u20131109","DOI":"10.2174\/1871520620666200824100408"},{"issue":"11","key":"3675_CR132","doi-asserted-by":"crossref","first-page":"e7826","DOI":"10.1371\/journal.pone.0007826","volume":"4","author":"H Zhang","year":"2009","unstructured":"Zhang H, Luo XQ, Zhang P, Huang LB, Zheng YS, Wu J, Zhou H, Qu LH, Xu L, Chen YQ (2009) MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia. PLoS ONE 4(11):e7826","journal-title":"PLoS ONE"},{"key":"3675_CR133","doi-asserted-by":"publisher","unstructured":"Zhang H, Luo X-Q, Feng D-D, Zhang X-J, Wu J, Zheng Y-S, Chen X, Xu L, Chen Y-Q (2011a) Upregulation of microRNA-125b contributes to leukemogenesis and increases drug resistance in pediatric acute promyelocytic leukemia. Mol Cancer 10:108. https:\/\/doi.org\/10.1186\/1476-4598-10-108","DOI":"10.1186\/1476-4598-10-108"},{"key":"3675_CR134","doi-asserted-by":"publisher","unstructured":"Zhang H, Luo X, Feng D, Zhang X, Wu J, Zheng Y, Chen X, Xu L, Chen Y (2011b) Upregulation of microRNA-125b contributes to leukemogenesis and increases drug resistance in pediatric acute promyelocytic leukemia. 1\u201313. https:\/\/doi.org\/10.1186\/1476-4598-10-108","DOI":"10.1186\/1476-4598-10-108"},{"issue":"4","key":"3675_CR135","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3892\/or.2012.1645","volume":"27","author":"BG Zhang","year":"2012","unstructured":"Zhang BG, Li JF, Yu BQ, Zhu ZG, Liu BY, Yan M (2012) MicroRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN. Oncol Rep 27(4):1019. https:\/\/doi.org\/10.3892\/or.2012.1645","journal-title":"Oncol Rep"},{"issue":"20","key":"3675_CR136","doi-asserted-by":"crossref","first-page":"20111","DOI":"10.18632\/aging.103614","volume":"12","author":"H Zhang","year":"2020","unstructured":"Zhang H et al (2020) MicroRNA-143 sensitizes acute myeloid leukemia cells to cytarabine via targeting ATG7-and ATG2B-dependent autophagy. Aging (Albany NY) 12(20):20111","journal-title":"Aging (Albany NY)"},{"issue":"4","key":"3675_CR137","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/1878-0261.12661","volume":"15","author":"H Zhang","year":"2021","unstructured":"Zhang H et al (2021) Long noncoding RNA DANCR confers cytarabine resistance in acute myeloid leukemia by activating autophagy via the miR-874-3P\/ATG16L1 axis. Mol Oncol 15(4):1203\u20131216","journal-title":"Mol Oncol"},{"issue":"1","key":"3675_CR138","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00018-023-05036-8","volume":"81","author":"X Zhang","year":"2023","unstructured":"Zhang X et al (2023) miR-181a plays the tumor-suppressor role in chronic myeloid leukemia CD34( +) cells partially via SERPINE1. Cell Mol Life Sci 81(1):10","journal-title":"Cell Mol Life Sci"},{"key":"3675_CR139","doi-asserted-by":"crossref","unstructured":"Zhang B, Nguyen LXT, Li L, Zhao D, Kumar B, Wu H, ... Marcucci G (2018) Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia. Nature Med 24(4):450\u2013462","DOI":"10.1038\/nm.4499"},{"key":"3675_CR140","unstructured":"Zhang, X.-T. et al (2019) MicroRNA-577 promotes the sensitivity of chronic myeloid leukemia cells to imatinib by targeting NUP160. Eur Rev Med Pharmacol Sci. 23(16)"},{"issue":"3","key":"3675_CR141","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1177\/0963689719825573","volume":"28","author":"H Zhou","year":"2019","unstructured":"Zhou H, Liu H, Jiang M, Zhang S, Chen J, Fan X (2019) Targeting microRNA-21 suppresses gastric cancer cell proliferation and migration via PTEN\/Akt signaling axis. Cell Transplant 28(3):306. https:\/\/doi.org\/10.1177\/0963689719825573","journal-title":"Cell Transplant"},{"key":"3675_CR142","doi-asserted-by":"publisher","unstructured":"Zhou Y, Zhu H, Han J, Xu Y, Wang D, Jin W, ... Qiao L (2023) miR-125b-5p suppresses leukemia cell proliferation by regulating MCL1.\u00a0J Environ Pathol Toxicol Oncol 42(1). https:\/\/doi.org\/10.1615\/JEnvironPatholToxicolOncol.2022041924","DOI":"10.1615\/JEnvironPatholToxicolOncol.2022041924"},{"issue":"7","key":"3675_CR143","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/carcin\/bgs179","volume":"33","author":"D-X Zhu","year":"2012","unstructured":"Zhu D-X et al (2012) miR-181a\/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes. Carcinogenesis 33(7):1294\u20131301","journal-title":"Carcinogenesis"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03675-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03675-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03675-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T10:51:43Z","timestamp":1748602303000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03675-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":143,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["3675"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03675-7","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,14]]},"assertion":[{"value":"11 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}